Steele Capital Management’s AbbVie ABBV Stock Holding History

Steele Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.2M	Sell	12,700 -99	-0.8%	-$21.3K	0.12%	57
2026 Q1	$2.78M	Sell	12,799 -382	-3%	-$84.7K	0.12%	60
2025 Q4	$3.01M	Buy	13,181 +1	+0%	+$228	0.13%	55
2025 Q3	$3.05M	Buy	13,180 +300	+2%	+$61.1K	0.14%	55
2025 Q2	$2.39M	Sell	12,880 -885	-6%	-$164K	0.11%	55
2025 Q1	$2.88M	Buy	13,765 +127	+0.9%	+$24.7K	0.15%	51
2024 Q4	$2.42M	Buy	13,638 +24	+0.2%	+$4.41K	0.13%	50
2024 Q3	$2.69M	Buy	13,614 +14	+0.1%	+$2.61K	0.14%	48
2024 Q2	$2.33M	Sell	13,600 -21	-0.2%	-$3.48K	0.13%	49
2024 Q1	$2.48M	Buy	13,621 +360	+3%	+$62K	0.14%	49
2023 Q4	$2.06M	Buy	+13,261	New	+$1.93M	0.13%	48

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Steele Capital Management's ABBV Position: Q2 2026 in Review

Steele Capital Management reduced its AbbVie (ABBV) stake by 0.77% in Q2 2026, selling an estimated $21.3K and leaving 12,700 shares worth $3.2M. The position accounts for 0.12% of the portfolio, ranked #57.

Steele Capital Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Steele Capital Management held 12,700 shares of AbbVie worth $3.2M as of Q2 2026.
Steele Capital Management sold 99 AbbVie shares in Q2 2026, an estimated $21.3K.
AbbVie made up 0.12% of Steele Capital Management's portfolio in Q2 2026, its #57 holding.
Steele Capital Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Steele Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.